<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02917473</url>
  </required_header>
  <id_info>
    <org_study_id>INCA14/LM-FADEMELA</org_study_id>
    <secondary_id>2016-A00186-45</secondary_id>
    <nct_id>NCT02917473</nct_id>
  </id_info>
  <brief_title>Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma</brief_title>
  <acronym>FADEMELA</acronym>
  <official_title>Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut national de la santé et de la recherche médicale, CIC 1415, TOURS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut national de la santé et de la recherche médicale, U930,TOURS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut d'Enseignement à Distance,University Paris - 8</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      First-degree relatives of patients with melanoma have a greater risk of developing melanoma.
      Patients are advised orally to inform their first-degree relatives that they should protect
      their skin from UV radiation and ask for a skin examination from a general practitioner or
      dermatologist. The study will evaluate the effectiveness of a written sheet in addition to
      the usual oral counselling to increase acceptance of skin examination by the first-degree
      relatives. If effective, written counselling provided to the patient for relatives should be
      recommended and generalized.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Melanoma (MM) is a common cancer affecting 11,000 new cases per year in France and the
      incidence has tripled in 30 years. It now includes young people, and is responsible for 1600
      deaths /year in France. Greater tumor thickness and delayed diagnosis are associated with
      higher mortality. Prevention and early detection on a large scale in the general population
      are effective but expensive. First-degree relatives have a greater risk of developing MM. A
      study carried out in the USA found that a biennial consultation is justified and
      cost-effective in first-degree relatives of MM patients. The best way to deliver the message
      of sun protection and screening by a dermatologist, and the reality of behavioural changes
      induced by counseling and the psychological determinants of adherence to medical skin
      examination are not fully understood.

      A pilot study performed in our center suggested the value of a short written advice provided
      for participants to give to their relatives to promote sun protection and medical skin
      examination. The participants reported a significant increase in interest in medical skin
      examination by their relatives (p=0.006), but the investigators do not know whether the
      relatives really consulted for examination.

      The aim of the multicenter cluster-randomized study is to demonstrate that a higher ratio of
      relatives will in fact consult their GP or dermatologist for skin examination in the centers
      randomized to the intervention arm, i.e advice leaflet and usual oral counselling, compared
      to the centers randomized in the control arm, i.e. usual oral counselling. Participants and
      their relatives in the intervention group will be asked to undergo psychological tests to
      identify potential barriers to skin examination and sun protection.

      If effective, the investigators expect to improve the written information and to generalize
      its distribution at national level.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2017</start_date>
  <completion_date type="Anticipated">November 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Consulting general practitioner or dermatologist</measure>
    <time_frame>1 year</time_frame>
    <description>The number of relatives who will have consulted a dermatologist or a general practitioner to perform whole body skin examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-skin examination reported by the relatives</measure>
    <time_frame>1 year</time_frame>
    <description>The number of relatives who declare to have performed Self-skin examination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sun protection behaviors reported by the relatives</measure>
    <time_frame>1 year</time_frame>
    <description>Sun protection behaviours reported by the relatives and assessed by a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barriers to skin examination identified from psychological questionnaires in patients and their relatives</measure>
    <time_frame>1 year</time_frame>
    <description>Psychological barriers of patients and their relatives to skin examination evaluated with several questionnaires and scales.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1125</enrollment>
  <condition>Melanoma</condition>
  <condition>Screening</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Education and counseling as commonly delivered to the patients in clinical practice.
Brief oral counseling to the patient focusing on sun protection, self-skin examination, medical skin examination, increased risk of melanoma for their first-degree relatives, who should be informed orally by the patients to protect themselves from UV radiation, perform self-skin examination and ask their GP or dermatologist to perform annual skin examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Education and counseling as commonly delivered to the patients in clinical practice and written advice for their first-degree relatives.
In addition to oral counseling to the patient, written advice will be provided to patients for their relatives focusing on sun protection, self-skin examination, medical skin examination, increased risk of melanoma for first-degree relatives, who should also be informed orally by the patients to protect themselves from UV radiation, perform self-skin examination and ask their GP or dermatologist to perform annual skin examinations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>In-person counseling</intervention_name>
    <description>In-person counseling
Sun protection</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written advice</intervention_name>
    <description>Written advice</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medical skin screening</intervention_name>
    <description>Medical skin screening</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For Patients:

          -  Personal history of Stage 0 through IIB melanoma

          -  At maximum of 12 weeks after surgical treatment of Stage 0 through IIA melanoma

          -  Have at least one first-degree relative

          -  Speaking and reading French

          -  Affiliated to the French Health Insurance system

          -  Signed non-opposition form at the 1 year consultation

        For 1st degree relatives:

          -  To be 1st degree related to a patient with melanoma

          -  Speaking and reading French

          -  1st degree relatives informed by patients and agreeing to fill out the psychological
             questionnaires and to the use of their personal data by the investigators.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent MACHET, MD-PHD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Tours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent MACHET, MD-PHD</last_name>
    <phone>+33(0)247478773</phone>
    <email>machet@univ-tours.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wiebe de JONG, MSc</last_name>
    <phone>+33(0)247474680</phone>
    <email>w.dejong@chu-tours.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU - ANGERS , Service de Dermatologie</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick Le Corre, MD-PHD</last_name>
      <phone>33 2 41 35 36 60</phone>
      <email>YaLeCorre@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Yannick Le Corre, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU BREST Hôpital du Morvan, Institut de Cancérologie et d'Hématologie</name>
      <address>
        <city>Brest</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Delphine LEGOUPIL, MD-PHD</last_name>
      <phone>+33(0)615371715</phone>
      <email>delphine.legoupil@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Delphine LEGOUPIL, MD-¨PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GH La Rochelle Ré Aunis-Service de Dermatologie</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe CELERIER, MD-PHD</last_name>
      <phone>+33546455183</phone>
      <email>philippe.celerier@ch-larochelle.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe CELERIER, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stépanie HOSTEING, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Le Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie BENETON-BENHARD, MD-PHD</last_name>
      <phone>+33(0)243434358</phone>
      <email>nbeneton@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie BENETON-BENHARD, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU NANTES, Service de Dermatologie</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaëlle QUÉREUX, MD-PHD</last_name>
      <phone>+33(0)2 40 08 31 44</phone>
      <email>gaelle.quereux@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Gaëlle QUÉREUX, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mélanie SAINT-JEAN, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brigitte DRÉNO, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU-Poitiers _LA MILETRIE POLE MEDIPOOL-DERMATO-ALLERGOLOGIE</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ewa WIERZBICKA-HAINAUT, MD-PHD</last_name>
      <phone>+33549444459</phone>
      <email>Ewa.HAINAUT@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Ewa Wierzbicka-HAINAUT, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU -RENNES -Service de Dermatologie-CHU Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain DUPUY, MD-PHD</last_name>
      <phone>+33(0)2 99 28 43 68</phone>
      <email>Alain.DUPUY@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Alain DUPUY, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lise BOUSSEMART, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica DINULESCU, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis -Service d'Oncologie médicale</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry LESIMPLE, MD-PHD</last_name>
      <phone>+33299253195</phone>
      <email>t.lesimple@rennes.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry LESIMPLE, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc PRACHT, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Tours, Service de Dermatologie</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent MACHET, MD-PhD</last_name>
      <phone>+33247478773</phone>
      <email>machet@med.univ-tours.fr</email>
    </contact>
    <contact_backup>
      <last_name>Wiebe de JONG, Msc</last_name>
      <phone>+33247474680</phone>
      <email>w.dejong@chu-tours.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Laurent MACHET, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morgiane BRIDOU, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahtab SAMIMI, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriela GEORGESCOU, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>September 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>April 25, 2018</last_update_submitted>
  <last_update_submitted_qc>April 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medical skin examination</keyword>
  <keyword>Skin Self Examination</keyword>
  <keyword>Sun protection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

